North America Vaccine Administration Devices Market, By Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Auto-Injector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, B.C.G. Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tender, Retail Sales) – Industry Trends and Forecast to 2030.
North America Vaccine Administration Devices Market Analysis and Size
Diabetic patients are becoming more prevalent over the world. Increasing immunization programs and campaigns and developing novel vaccines are the primary drivers which boosted the market's demand in the forecast period 2023-2030. Several technological advancements to efficiently deliver vaccines are anticipated to boost the market growth. The urgency to locate and oversee a COVID-19 vaccine has caused interest in offering an effective and safe viral delivery system or multiple delivery systems.
Data Bridge Market Research analyses a growth rate in the vaccine administration devices market in the forecast period 2023-2030. The expected CAGR of the vaccine administration devices market tends to be around 8.5% in the mentioned forecast period. The market is valued at USD 1,905.54 million in 2022 and will grow to USD 3,659.78 million by 2030. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
North America Vaccine Administration Devices Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2023 to 2030
|
|
Base Year
|
2022
|
|
Historic Years
|
2021 (Customizable to 2015 - 2020)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Product (Syringes, Auto Injectors, Jet Injectors, Micro Needles, Inhalation/Pulmonary Delivery, Microinjection System, Pen Injector Devices, Biodegradable Implants, Electroporation-Based Needle Free Injection Systems, Buccal /Sublingual Vaccine Delivery Systems, Auto-Injector Trainer Devices and Others Devices), Route of Administration (Intramuscular, Subcutaneous, Intradermal), Type (Marketed Vaccines and Clinical-Stage Vaccines (Electroporation)), Brand (BD Accuspray Nasal Spray System, BD Hypak for Vaccines Glass Pre-Fillable Syringe System, BD Uniject Auto-Disable Pre-Fillable Injection System, Gx InnoSafe, Gx RTF ClearJect, Plajex, Others), Dosage (Fixed and Variable), Vaccine Type (Bivalent Oral PolioVaccine, B.C.G. Vaccine, Tetanus-Diphtheria Vaccine, DTP-HEPB-HIB Vaccine, Influenza Vaccine, Pneumococcal Conjugate Vaccine, Measles Vaccine, Others), Modality (Automatic Vaccine Administration Device and Manual Vaccine Administration Device), Usability (Disposable and Reusable), End User (Hospitals, Community Centers, Homecare Setting, Research and Academic Institutes, Ambulatory Surgical Center, Others), Distribution Channel (Direct Tender, Retail Sales)
|
|
Countries Covered
|
U.S., Canada and Mexico
|
|
Market Players Covered
|
B.D. (U.S.), INOVIO Pharmaceuticals (U.S.), Vaxxas (U.S.), Gerresheimer AG (Germany), Corium Inc. (U.S.), Enesi (U.S.), Micropoint Technologies (Singapore), SCHOTT AG (Germany), 3M (U.S.), Mystic Pharmaceuticals (U.S.), NanoPass Rev (U.S.), Terumo North America NV (Belgium), D'Antonio Consultants International, Inc. (U.S.), West Pharmaceutical Services, Inc. (U.S.)., Mylan N.V. (U.S.), Medical International Technologies Inc. (Canada), Antares Pharma (U.S.)
|
|
Market Opportunities
|
|
Market Definition
Vaccines is defined as a set of biological preparations that protect humans from viruses and bacteria-related infections. Some of the vaccine kinds are live/attenuated vaccines, inactivated/killed vaccinations, toxoid vaccines, and conjugate vaccines. Using a syringe or needle, vaccines are administered intramuscularly or subcutaneously. Disposable syringes, micro-needles, jet injectors, and intradermal delivery devices for inactivated poliovirus vaccines are some of the other vaccine administration methods.
North America Vaccine Administration Devices Market Dynamics
Drivers
- Growing Demand for Pain-free Needles
The rising demand of pain-free needles associated with the vaccination to avoid pain is boosting the market growth. According to CDC, approximately 385,000 injuries which also includes needle-caused injuries in U.S. are boosting the market growth. Thus, to avoid these kind of injuries, the demand of this type of needles is increasing, this factor increases the growth of the market.
- Rising Government Initiatives
Numerous initiatives government agencies take to manufacture new vaccines offer opportunities for growth in the market. For instance, the National Institute of Allergy and Infectious Diseases (NIAID) launched a clinical trial to evaluate three H.I.V. vaccines in their experimental phase in 2022. The vaccines are based on a messenger R.N.A. platform, a technology previously used in multiple approved COVID-19 vaccines. Thus, this boosts market growth.
Opportunities
- Growing Demand for Intradermal Vaccination
The intradermal route of administration has attracted much attention in the past few years due to benefits such as improved safety, dose sparing, and improved access to vaccines. These factors are anticipated to lead to market growth over the following years. Additionally, a rise in the studies of alternative methods for intradermal administration with several novel devices such as jet injectors and microneedles, is expected to enhance the market growth.
- Increasing R&D Activities
There are expansions and major funding for R&D activities that are adopted by top companies to increase the market growth. For instance, vaccines developed by the Serum Institute of India acquired a 50% share in a pharma packing firm, Schott Kaisha in 2021. This initiative led the Serum Institute of India to be in a joint venture with Schott AG which is a specialty glass company based in Germany. Thus, this factor boosts the market growth.
Restraints/Challenges
- High Cost Associated with Vaccine Administration Devices
The increasing expenditure associated with the devices impede the market growth. The high cost of vaccines, installation and setting up of multiple devices, high cost involved with the training and maintenance of people for handling these vaccines increase the total cost of the market. These all factors hamper the growth of the market.
This vaccine administration devices market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the vaccine administration devices market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Recent Development
- In 2020, B.D. (Becton, Dickinson, and Company) entered into a partnership with the United States Government to eliminate tuberculosis in Indonesia. The company is widely engaged in manufacturing needles and syringes used for vaccination, and the U.S. government stresses on vaccine administration program. This partnership assisted the company to increase its platform for manufacturing vaccine syringes and needles.
North America Vaccine Administration Devices Market Scope
The vaccine administration devices market is segmented on the basis of product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Product
- Syringes
- Auto Injectors
- Jet Injectors
- Micro Needles
- Inhalation/Pulmonary Delivery
- Microinjection System
- Pen Injector Devices
- Biodegradable Implants
- Electroporation-Based Needle Free Injection Systems
- Buccal /Sublingual Vaccine Delivery Systems
- Auto-Injector Trainer Devices
- Others Devices
Route of Administration
- Intramuscular
- Subcutaneous
- Intradermal
Type
- Marketed Vaccines
- Clinical-Stage Vaccines (Electroporation)
Brand
- BD Accuspray Nasal Spray System
- BD Hypak for Vaccines Glass Pre-Fillable Syringe System
- BD Uniject Auto-Disable Pre-Fillable Injection System
- Gx InnoSafe
- Gx RTF ClearJect, Plajex
- Others
Dosage
- Fixed
- Variable
Vaccine Type
- Bivalent Oral PolioVaccine
- B.C.G. Vaccine
- Tetanus-Diphtheria Vaccine
- DTP-HEPB-HIB Vaccine
- Influenza Vaccine
- Pneumococcal Conjugate Vaccine
- Measles Vaccine
- Others
Modality
- Automatic Vaccine Administration Device
- Manual Vaccine Administration Device
Usability
- Disposable
- Reusable
End User
- Hospitals
- Community Centers
- Homecare Setting
- Research and Academic Institutes
- Ambulatory Surgical Center
- Others
Distribution Channel
- Direct Tender
- Retail Sales
Vaccine Administration Devices Market Regional Analysis/Insights
The vaccine administration devices market is analyzed and market size insights and trends are provided by product, route of administration, type, brand, dosage, vaccine type, modality, usability, end user, and distribution channel as referenced above.
The major countries covered in the vaccine administration devices market report are U.S., Canada and Mexico
U.S. is anticipated to grow with the highest CAGR in the forecast period due to the growing demand for vaccine administration devices for the fixed vaccine administration devices segment. Also, several governments globally are growing their spending on vaccination and demonstrating strong and effective leadership and ownership of immunization programs in this region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of North America brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and North America Vaccine Administration Devices Market Share Analysis
The vaccine administration devices market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, North America presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to vaccine administration devices market
Key players operating in the vaccine administration devices market include:
- Medtronic (Ireland)
- Stening S.R.L. (Argentina)
- Cook (U.S.)
- Bicakcilar Medical (Istanbul)
- TROGE MEDICAL GmbH (Germany)
- Henan Tuoren Medical Device Co., Ltd. (China)
- Fisher & Paykel Healthcare Limited (new Zealand)
- Medis Medical (U.K.) Ltd (U.K.)
- Pulmodyne, Inc. (U.S.)
- Fuji Systems (Japan)
- DEAS S.R.L. (Italy)
- Sterimed Group (India)
- ConvaTec Group PLC (U.K.)
- Smiths Medical (U.K.)
- Andreas Fahl Medizintechnik – Vertrieb GmbH (Germany)
- Boston Medical Products Inc. (U.S.)
- TRACOE medical GmbH (Germany)
- Teleflex Incorporated (U.S.)
- Well Lead Medical Co., Ltd (China)
SKU-